ABC00845HZ

Levothyroxine EP impurity D

Levothyroxine EP Impurity D is a structurally related degradation byproduct of levothyroxine, characterized by the loss of a methylamino group and retention of four iodine atoms on a substituted tetrahydrobenzofuran ring system. Its core scaffold retains conjugated aromaticity with hydroxyl and ketone functionalities at positions 3 and 5 of the phenolic moiety, while the side chain lacks the N-methyl substitution present in the parent drug. This impurity arises via oxidative deamination during synthesis or storage, forming a stable, fully iodinated cyclic ether derivative. It serves as a critical HPLC reference standard for quantitative impurity profiling in levothyroxine bulk drug substance analysis.

On Request
Molecular Formula C14H8I4O4
Molecular Weight 747.8300
CAS Number 67-30-1 โœ“ Verified
PubChem CID 65552 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Levothyroxine
Lead Time On Request
IUPAC Name 2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid
Official Reference Standards
Std Catalog # Quantity Price
USP 1A11700 โ†— 25 mg USD 850.00

๐Ÿ“ Synonyms

Tetrac 67-30-1 3,3',5,5'-TETRAIODOTHYROACETIC ACID Tetraiodothyroacetic acid T4-acetic acid PA7UX1FFYQ Thyroacetic acid, 3,3',5,5'-tetraiodo- 3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid Acide 3,5,3',5'-tetraiodothyroacetique DTXSID5048186

๐Ÿ”ฌ Chemical Identifiers

C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(=O)O
InChI=1S/C14H8I4O4/c15-8-4-7(5-9(16)13(8)21)22-14-10(17)1-6(2-11(14)18)3-12(19)20/h1-2,4-5,21H,3H2,(H,19,20)
PPJYSSNKSXAVDB-UHFFFAOYSA-N

Related Products